✦ LIBER ✦

Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer

✍ Scribed by Taher A. Al-Tweigeri; Dahish S. Ajarim; Adher A. Alsayed; Mohamed M. Rahal; Mohamed O. Alshabanah; Asma M. Tulbah; Osama A. Al-Malik; Doha M. Fatani; Gamal A. El-Husseiny; Naser B. Elkum; Adnan A. Ezzat

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 272 KB
Volume: 27
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-009-9251-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of docetaxel, capecitabin

Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer

✍ Yen-Shen Lu; Dar-Ren Chen; Ling-Min Tseng; Dah-Cherng Yeh; Shou-Tung Chen; Chia- 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

Phase II study of neoadjuvant treatment

Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer

✍ Gumersindo Pérez Manga; Parham Khosravi Shahi; Miguel Méndez Ureña; Rosa Quiben 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 214 KB

A phase II study of neoadjuvant docetaxe

A phase II study of neoadjuvant docetaxel plus doxorubicin (KBCS-01) in stage II, III breast cancer

✍ Sehwan Han; Sung Bae Kim; Sung S. Kang; Woo C. Noh; Nam S. Paik; Eil S. Chang; J 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 177 KB

Neoadjuvant chemotherapy with cisplatin,

Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study

✍ Katja Ott; Andreas Sendler; Karen Becker; Hans-Joachim Dittler; Hermann Helmberg 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 191 KB

Phase II Trial of Neoadjuvant Chemothera

Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer

✍ Bhuvaneswari Ramaswamy; Steven P Povoski; Chris Rhoades; Joan Allen; Marsha Haug 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 227 KB

Phase II study of dose-dense doxorubicin

Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer

✍ Jesús García-Mata; Andrés García-Palomo; Lourdes Calvo; Ramón Mel; Juan Jesús Cr 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 240 KB